January 31 (SeeNews) - Bulgarian medical consumables producer Etropal [BUL:ETR] said its non-consolidated net loss narrowed to 138,000 levs ($76,929/70,558 euro) last year from a net loss of some 3.8 million levs in 2021.
Etropal's total revenue declined to 5.7 million levs in 2022 from 7 million levs a year earlier, the company said in an interim financial statement on Monday. Revenue from product sales slipped to 3.5 million levs in the period under review from 4.4 million levs.
Operating expenses shrank 57.5% on the year to 5.5 million levs, as costs for materials dropped by 31.3% to 2.5 million levs, along with declines in expenses for hired services and personnel.
The company's assets grew to 18 million levs at the end of last year from 16.6 million levs in 2021.
Etropal specialises mainly in the production of consumables for hemodialysis.
Shares in Etropal last traded at 6.20 levs on the Bulgarian Stock Exchange, bourse data show.
(1 euro = 1.95583 levs)